Our President Lucia Beviglia is an expert in cancer biology and pharmacology, life sciences, biopharmaceuticals and biotechnology. She founded a preclinical consulting and service provider company out of her passion for cancer research and drug discovery. She has experienced that high diligence and experimental rigor are required to conduct properly preclinical investigations increasing success in the clinic. She has been recognized for her exceptional skills in pharmacological modeling of different disease areas, primarily cancer and immuno-oncology and additionally blood hematology and inflammation. Since 2000, Dr. Beviglia had leadership positions at pharmaceutical and research organizations in the Bay Area. She became also very experienced and successful at providing cancer efficacy contract services working at the interface between science and business development to help numerous Clients validate in vivo their proprietary drug candidates. Before landing to industry, she worked on several research projects at prestigious Universities in Italy and USA (Mario Negri Institute, Temple University, UCSF, UNC-Linerberger Cancer Center). Since 2013, Lucia has eRA Commons account with NIH and can help Clients and Collaborators as co-Investigator or Scientific Consultant in gran-funded research work. She has advanced degrees in Biological and Biomedical Sciences (Ph.D. and Specialist degrees) and during her career has received multiple awards and authored more than 30 publications.